Citadel Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.14M | Buy |
|
|||||
|
2025
Q2 | $536K | Buy |
|
|||||
|
2025
Q1 | $113K | Sell |
|
|||||
|
2024
Q4 | $9.75M | Buy |
|
|||||
|
2024
Q3 | $10M | Sell |
|
|||||
|
2024
Q2 | $18.4M | Buy |
|
|||||
|
2024
Q1 | $60.7M | Buy |
|
|||||
|
2023
Q4 | $55.8M | Buy |
|
|||||
|
2023
Q3 | $43.2M | Buy |
|
|||||
|
2023
Q2 | $60.1M | Buy |
|
|||||
|
2023
Q1 | $22.9M | Buy |
|
|||||
|
2022
Q4 | $12.8M | Buy |
|
|||||
|
2022
Q3 | $12M | Sell |
|
|||||
|
2022
Q2 | $21.4M | Buy |
|
|||||
|
2022
Q1 | $23.6M | Sell |
|
|||||
|
2021
Q4 | $50.4M | Sell |
|
|||||
|
2021
Q3 | $73.5M | Sell |
|
|||||
|
2021
Q2 | $65.6M | Buy |
|
|||||
|
2021
Q1 | $45.8M | Sell |
|
|||||
|
2020
Q4 | $78.1M | Sell |
|
|||||
|
2020
Q3 | $55.2M | Buy |
|
|||||
|
2020
Q2 | $74.9M | Buy |
|